# Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

> **NCT02790632** · PHASE3 · TERMINATED · sponsor: **Edge Therapeutics Inc** · enrollment: 374 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DRUG:** EG-1962 (nimodipine microparticles)
- **DRUG:** Enteral Nimodipine

## Key facts

- **NCT ID:** NCT02790632
- **Lead sponsor:** Edge Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-07
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 374 (ESTIMATED)
- **Why stopped:** DMC review concluded study has a low probability of meeting its primary endpoint
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02790632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02790632, "Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02790632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*